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Abstract
Background: B cells and humoral immune responses play an important role in the pathogenesis and diagnosis of multiple
sclerosis (MS). A characteristic finding in patients with MS is a polyspecific intrathecal B cell response against neurotropic
viruses, specifically against measles virus, rubella virus, and varicella zoster virus, also known as an MRZ reaction (MRZR).
Here, we correlated from the routine clinical diagnostics individual IgG antibody indices (AIs) of MRZR with magnetic
resonance imaging (MRI) findings in patients with first MS diagnosis.
Methods/Results: MRZR was determined in 68 patients with a clinically isolated syndrome (CIS) or early relapsing-remitting
MS (RRMS). Absolute AI values for measles virus, rubella virus, and varicella zoster virus were correlated with T2 lesion load
and gadolinium enhancing lesions on cerebral MRI (cMRI) and cMRI combined with spinal MRI (sMRI). Measles virus AI
correlated significantly with T2 lesion load on cMRI (p=0.0312, Mann-Whitney U test) and the sum of lesions on cMRI and
sMRI (p=0.0413). Varicella zoster virus AI also showed a correlation with T2 lesion load on cMRI but did not reach statistical
significance (p=0.2893).
Conclusion: The results confirm MRZR as part of the polyspecific immune reaction in MS with possible prognostic impact on
MRI and clinical parameters. Furthermore, the data indicate that intrathecal measles virus IgG production correlates with
disease activity on cMRI and sMRI in patients with early MS.
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Introduction
Great effort hasdone intodefiningprognosticmarkersinmultiple
sclerosis (MS) over recent years. To date, a combination of clinical,
cerebrospinal fluid (CSF) and MRI variables are used to predict
disease course. Research has shown high T2 lesion load on cMRI at
diagnosis is associated with a more active disease course [1,2] and in
clinical routine, T2 lesion load and gadolinium enhancement are
the most important markers in evaluating disease activity.
CSF is a promising source of biochemical markers in MS, as its
compounds are relevant not only in the diagnosis of MS but may
also reflect disease activity. Detection of oligoclonal bands in CSF
and at least two positive AI against measles virus, rubella virus and
varicella zoster virus of $1.5 (MRZR), are important markers in
the diagnosis of MS. In 80–100% of patients with MS, a
polyspecific intrathecal B cell response in the form of a positive
MRZR is detectable in CSF and is accepted as being highly
specific for this disease [3,4]. Furthermore, other studies have
shown a correlation between disease activity and both intrathecal
IgM synthesis and an elevated B cell monocyte ratio, which
emphasizes the importance of humoral response in MS [5–7].
In the present study, we correlated from the routine clinical
diagnostics absolute AIs for measles virus, rubella virus, and
varicella zoster virus (VZV) with magnetic resonance imaging
(MRI) parameters of disease activity in patients with a first
diagnosis of clinically isolated syndrome (CIS) or early RRMS.
Methods
Patients
61patients with relapsing-remitting MS according to the revised
McDonald criteria from 2010 [8] and 7 patients with a CIS,
who were treated at the Department of Neurology, Charite ´–
Universita ¨tsmedizin Berlin between 2007 and 2010, were enrolled
in this study. All patients presented with first clinical symptoms of
the disease and underwent lumbar puncture and cerebral MRI as
part of the routine diagnostic work-up. Additionally, 44 patients in
the group underwent spinal MRI. All patients had positive
oligoclonal bands in their CSF. At the time of investigation no
patient was being treated with steroids or immunomodulatory or
immunosuppressive substances. The patient data was anonymized
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Hospital ethics committee. We do not have informed consent from
our patients. According to Charite ´ University Hospital ethics
committee in case of use of routine parameters and anonymized
data it is not necessary to obtain informed consent from patients.
Determining MRZ reaction
Antibodies against measles virus and VZV were measured
in serum and CSF samples using commercial enzyme-linked
immunosorbent assays (ELISA; Enzygnost, Siemens Healthcare
Diagnostics, Germany) according to the manufacturer’s instruc-
tions. Antibodies against rubella virus were also measured by
ELISA (medac, Wedel, Germany). A standard curve consisting of
serial dilutions of a standard human plasma (SHP, Siemens
Healthcare Diagnostics) was included on each ELISA plate. The
same batch of SHP was used for all experiments. Total albumin
and IgG concentration in serum (IgG (serum)) and CSF were
measured nephelometrically (BN ProSpec, Siemens Healthcare
Diagnostics).
AI values were calculated either with the formula: AI=(IgGspec
CSF/IgGspec serum)/(IgGtotal CSF/IgGtotal serum)=Qspec/QIgG
if QIgG,QLim,o rA I = Q spec/QLim if QIgG.QLim.Q Lim was
calculated as described previously (Reiber and Peter, 2001). AI
values $1.5 were considered as indicative of an intrathecal virus-
specific antibody production.
MRI analysis
All 67 patients underwent cerebral MRI concurrently with the
spinal tap. The majority of patients were scanned on a 1.5 T MRI
unit according to a a previously fixed protocol including T1-
weighted spin-echo (SE) axial slices with and without application
of gadolinium as well as T2-weighted SE axial slices. Hyperintense
lesion on T2-weighted MRI lesions .3m m
2 were analyzed and
quantified on hardcopies. For this study, the presence of $1
lesions suggestive of MS in T2 weighted MRI as well as Barkhof
criteria [1] were used as diagnostic criteria.
Statistical analysis: Statistical significance of differences in absolute
AI values between patients with high and low lesion loads in T2-
weighted images and patients with and without Gd-enhancing
lesions were analysed by Mann-Whitney U test using GraphPad
Prism 5 software. P values ,0.05 were considered significant.
Results
The demographic data of all patients included in this study are
shown in Table 1. A positive MRZ reaction as defined by a
combination of at least two positive AIs was present in 38 of 66
patients (57.57%). The German Multiple Sclerosis Therapy
Consensus Group supposes an increased MS risk in CIS patients
with $6 T2 lesions and recommends an early therapy for these
patients because of higher disease activity [9]. To correlate AI
levels with T2 lesion load on cMRT, the patients were divided into
two groups: those with ,6 lesions and those with $6 lesions.
Mean absolute AI values for measles virus, rubella virus, and
varicella zoster virus were compared between both groups.
Patients with $6 T2 lesions had a higher mean measles AI than
patients with ,6 T2 lesions (p=0.0312). For 44 patients, both
cerebral and spinal MRI was available. When cerebral and spinal
T2 lesions were taken together, a significant difference of mean
measles virus AI values between patients with higher ($6) and
lower (,6) lesion load was observed (p=0.0413, see Figure 1A).
The comparison of AI means against VZV revealed a tendency
toward a higher AI in the group of patients with higher lesion load,
which did not reach statistical significance (p=0.2893, see
Figure 1C). For rubella virus, mean absolute AI values did not
differ between the two groups (see Figure 1B).
But rubella virus AI also showed a correlation with Gd-
enhancing lesions on combined cerebral and spinal MRI but did
not reach statistical significance (p=0.0611). Furthermore, none of
the other AIs correlated with the presence of Gd-enhancing lesions
(see Figure 1).
We also performed a Spearman Rank Correlation for single AIs
and the number of T2 or Gd-enhancing lesions, which did not
yield any statistically significant results (see Figure S1).
Discussion
We investigated the relationship between the levels of the
individual IgG AIs that form the MRZ reaction and quantitative
MRI outcomes in patients with MS. Higher anti-measles AI levels
were associated with a higher T2 lesion load in cMRI and sum of
T2 lesions in cerebral and spinal MRI. There was no link between
individual MRZ-IgG AIs and Gd-enhancing lesions as a marker of
acute inflammation on cMRI.
MRZ reaction in CSF is positive in chronic CNS autoimmune
diseases (e.g. neurolupus or CNS-vasculitis), but has been proposed
as a specific marker for autoimmunity in MS [4]. Positive
detection varies at between 42% and .90% in newly diagnosed
CIS or MS patients depending on the inclusion criteria used by the
study in question [10]. We detected a positive MRZ reaction in
57.57% of our patients, with VZV as the most frequent single AI.
Brettschneider et al. defined a scoring system based on the MRZR
to predict the development of relapsing-remitting MS (RRMS)
from CIS, and found these AI indicators to have more prognostic
Table 1. Demographic data of all 68 patients. MRZR+=AI for measles virus, rubella virus, varicella zoster virus, two or more AI$1.5.
n Patients Patients in %
(Female/male) 48/20 71%/29%
Age (years) at MS onset as median (range) 30 (18–64)
Sample acquisition age (years) as median (range) 31 (18–64)
Diagnosis CIS/RRMS 7/61 10,29%/89,71%
Measles AI$1.5/,1.5 31/36 46.27%/53.73%
Rubella AI$1.5/,1.5 36/30 54.54%/45.46
Zoster AI$1.5/,1.5 47/21 69.12%/30.88
MRZR+ 38 57.57%
doi:10.1371/journal.pone.0028094.t001
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[11]. To date MRZR has been understood as polyspecific CNS
antibody production directed against diverse common neurotropic
viruses [12–14]. Intrathecal IgG synthesis in MS is widely known
to be stable and clonally uniform over time [15] and possibly high
MRZ AIs signal indicate B cell activity, which has been associated
with more severe disease progression in previous studies [5]. In our
study we categorized the patients into two groups, namely those
with low initial lesion numbers (less than 6) and those with a high
number of lesions (6 or more) and see significant higher measles AI
levels in the last group but failed to show a direct correlation
between viral IgG AI levels and T2 lesion load in MRI (see Figure
S1). We explain this finding with the above mentioned observation
that oligoclonal bands and intrathecal IgG production are stable
markers [15] that may reflect overall disease activity. In MS cMRI
lesion load usually increases over time while IgG production is
stable (see Figure S2). As a consequence we can not expect a direct
correlation between both parameters. For this reason both
markers (IgG level and IgG AI) correlate with number of MRI
lesions only at the beginning of the disease and may have
prognostic implication (see Figure S3).
On the other hand MRI T2 lesion load has an important
clinical impact in diagnosis of MS and therapeutic decisions. The
number of lesions in CIS correlates with the risk of conversion to
clinically definite MS and is used to monitor disease activity [16].
In conclusion, our data suggest that measles AIs correlate with
MRI markers in early MS and increased measles AI levels are a
marker of increased disease activity. The study underlines the
relevance of humoral immunity in MS pathogenesis and supports
MRZR as an important tool not only in MS diagnosis but also to
estimate disease activity. Additional longitudinal studies are
needed to investigate the relationship between MRZ AIs and
MRI parameters on one hand and clinical aspects like neurocog-
nitive function and disability progression on the other.
Supporting Information
Figure S1 Measle virus IgG AI and T2 lesion load in
MRI. Correlation between number of T2 lesions in cerebral MRI
(A), including 67 patients, and sum of lesions in cerebral and spinal
MRI (sMRI) (B) from 43 patients with IgG AI for measles virus.
(TIF)
Figure S2 Correlation between symptom duration and
total intrathecal IgG synthesis. Correlation of time between
first symptoms (FS) and lumbal puncture (LP) and total intrathecal
IgG synthesis from 65 patients.
(TIF)
Figure S3 Total intrathecal IgG and T2 and Gd-
enhancing lesion load in MRI. Comparison of mean total
intrathecal IgG for patients with ,6 lesions and $6 lesions in
cMRI (A) and both cMRI and sMRT (B). Comparison of mean
total intrathecal IgG for patients with Gd-enhancing and no Gd-
enhancing lesions in cMRI (C) and both cMRI and sMRI (D).
(TIF)
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Figure 1. IgG antibody index of MRZR and MRI activity. IgG antibody index (AI) results for measles virus (A), rubella virus (B) and varicella
zoster virus (C) for patients with ,6 lesions, $6 lesions, no Gd-enhancing lesions and Gd-enhancing lesions on cMRI are shown as box plot graphs.
The boxes include values between the 25
th and 75
th percentile of the distribution, while the line within the box represents the median value. The
whiskers above and below the box indicate the 90
th and 10
th percentile, respectively, and the black dots indicate the outliers, while the dotted line at
AI 1.5 indicates the upper limit of the reference range. The number of patients in each group is shown in brackets above boxes.
doi:10.1371/journal.pone.0028094.g001
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